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Autism Spectrum Disorder (ASD) is associated with atypical Autonomic Nervous System 38 
(ANS) function. However, little is known about this relationship, whilst accounting for co-39 
occurring mental health conditions (e.g., anxiety) that are also associated with ANS 40 
dysfunction. Additionally, research on the ANS has typically involved physiological 41 
measurements, without using more clinically meaningful measures of ANS dysfunction, such 42 
as the self-reported frequency of ANS-related physical health symptoms. Furthermore, very 43 
little is known about ANS function in autistic adults, given that previous research has focused 44 
on ANS dysfunction in children with ASD. Addressing these gaps in the literature, we 45 
compared ANS function in adults with(out) ASD (Study 1). Although autistic adults reported 46 
greater ANS dysfunction than matched neurotypical controls, this difference was not 47 
significant after controlling for anxiety and depression. Similarly, in a large non-clinical 48 
sample (Study 2), we found that anxiety and stress mediated the relationship between autistic 49 
traits and ANS dysfunction. Together, we conclude that ANS dysfunction is not a feature of 50 
ASD per se, but instead attributable to the high levels of anxiety and stress in autistic adults. 51 
We discuss the clinical relevance of these findings for managing ANS dysfunction and other 52 
physical and mental health concerns in autistic adulthood. 53 
 54 
Key Words: Autism Spectrum Disorder, Autonomic Nervous System, Heart Rate Variability, 55 
Anxiety.  56 
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Autism Spectrum Disorder (ASD) frequently co-occurs with a range of mental (Lai et 57 
al., 2019) and physical health conditions (Underwood et al., 2019). In exploring the 58 
neurobiological underpinnings of ASD and co-occurring conditions, there has been growing 59 
interest in the Autonomic Nervous System (ANS). ANS dysfunction affects the functioning 60 
of the heart, bladder, pupils, and several other bodily functions, and can result in a wide range 61 
of physical health problems, such as dizziness, abnormal sweating, digestive difficulties and 62 
urinary problems (Cheshire, 2012), and equally, can disrupt mental processes (e.g., social 63 
cognition; Porges & Furman, 2011). Therefore, elucidating the link (if any) between ASD 64 
and ANS dysfunction has potential to explain several symptoms of ASD and co-occurring 65 
health conditions. Although some research indicates that ASD is associated with ANS 66 
dysfunction (see Benevides & Lane, 2015 for review), there remain several major gaps and 67 
inconsistencies in this literature that we address in the present study. 68 
First, previous research has focused on autistic children, whereas there is very little, 69 
and highly inconsistent, research on the ANS in autistic adults. Studies have shown that, 70 
when measured in terms of heart-rate (HR) baseline and variability, autistic adults show 71 
either atypical (e.g., Thapa et al., 2019) or equivalent (e.g., Smeekens, Didden, & Verhoeven, 72 
2015; Toichi & Kamio, 2003) ANS function compared to matched neurotypical (NT) 73 
controls. Additional research is therefore required to establish, more conclusively, whether 74 
ANS function is atypical in autistic adults.  75 
Second, previous research on ANS function in ASD has relied on physiological 76 
measurements (e.g., HR). While these methods permit measurement of a single 77 
neurobiological process, they do not capture ANS processes in the context of real-world 78 
situations, such as the physical symptoms of ANS dysfunction (e.g., dizziness) and related 79 
health concerns (e.g., gastrointestinal disturbance). Therefore, findings from studies of 80 
physiological measurements, when used alone, have limited utility for understanding and 81 
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managing ANS dysfunction in clinical settings. Conversely, clinical questionnaire measures – 82 
widely-used by neurologists to measure physical symptoms of ANS dysfunction in other 83 
conditions (e.g., Fibromyalgia; Vincent, Whipple, Low, Joyner, & Hoskin, 2016) – are 84 
required in ASD research and will be useful in clinical practice, as they are an accessible tool 85 
for exploring and quantifying daily experiences of ANS dysfunction. Additionally. in contrast 86 
to physiological measurements, these questionnaire measures assess ANS function across 87 
multiple domains (e.g., vasomotor, gastrointestinal etc.) offering the advantage of a broader 88 
and more complete characterisation of the potentially affected processes. Previously, scores 89 
on such measures have been shown to predict ANS dysfunction assessed using physiological 90 
measures, which are considered a reliable screening tool for several disorders characterised 91 
by ANS dysfunction (e.g., Kim et al., 2017; Treister, O’Neil, Downs & Oaklander, 2015).  92 
Finally, the specificity of previously identified ANS dysfunction in ASD is unclear. 93 
Outside of autism research, ANS dysfunction has consistently been associated with anxiety 94 
and sometimes depression (see Alvares, Quintana, Hickie, & Guastella, 2016 for meta-95 
analysis). Yet, despite high rates of co-occurring anxiety and depression in ASD (e.g., 96 
Hollocks, Lerh, Magiati, Meis-Stedman, & Brugha, 2019), little research has measured or 97 
statistically accounted for depression and anxiety levels when examining ANS dysfunction in 98 
ASD (see McVey, 2019). Crucially, this may explain why the (limited) research on ANS 99 
function in autistic adulthood is inconsistent. It is possible that, in studies finding group 100 
differences in ANS function (e.g., Thapa et al., 2019), autistic participants had higher levels 101 
of anxiety and depression than NT controls. Equally, it is plausible that, in studies finding no 102 
group differences in ANS function, autistic and non-autistic participants happened to have 103 
similar levels of anxiety and depression. Accordingly, in astudy including anxiety measures 104 
(but not depression), autistic children with anxiety showed greater ANS dysfunction 105 
compared to those with low levels of anxiety (Panju, Brian, Dupuis, Anagnostou, & K shki, 106 
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2015). However, it was unclear from the statistical analysis if  there was a unique association 107 
between ASD and ANS dysfunction after accounting for anxiety. And, critically, there is no 108 
research on the ANS in autistic adults, whilst accounting for anxiety or other conditions 109 
linked to ANS dysfunction. Addressing these gaps in the literature, we compared self-110 
reported ANS function in autistic and NT adults, whilst accounting for anxiety and 111 
depression (Study 1). Following previous research, we predicted that autistic adults would 112 
report greater ANS dysfunction than NT controls, however we expected that this would be 113 
attributable to high anxiety and/or depression levels in ASD. 114 
 115 
Study 1 116 
Method 117 
Participants. Forty-four adults were recruited (22 with and 22 without a clinical 118 
autism diagnosis). Participants with ASD formed a convenience sample and were matched 119 
with a community sample of neurotypical (NT) participants. Participants in both groups had 120 
been recruited via adverts on local noticeboards and social media, forming a community 121 
database of autistic and non-autistic volunteers that were invited to participate. Participants 122 
with ASD had been diagnosed by an independent clinician according to the Diagnostic and 123 
Statistical Manual of Mental Disorders (American Psychiatric Association, 2013). 124 
Additionally, they scored a minimum of 7 on the social-communication total score of the 125 
Autism Diagnostic Observational Schedule (ADOS; Lord et al., 2000). Non-autistic NT 126 
participants confirmed they did not have ASD, as evidenced by significantly lower scores on 127 
the 50-item Autism-Spectrum Quotient (AQ; Baron-Cohen, Wheelwright, Skinner, Martin, & 128 
Clubley, 2001; see Table 1). Groups were age-, sex- and IQ-matched (Table 1) using the full-129 
scale Wechsler Abbreviated Scale of Intelligence (Wechsler, 2011). Due to the potential 130 
effects on ANS function, individuals with serious cardiovascular diseases (e.g., Coronary 131 
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Artery Disease) and/or on medication that directly affect cardiac rhythm (e.g., beta blockers) 132 
were not eligible to participate. Participants taking certain anti-anxiety and depression 133 
medication (e.g., Selective Serotonin Reuptake Inhibitors) were included in the study. There 134 
were no other exclusion criteria and participants were not included based on other 135 
characteristics, behaviours, or for seeking treatment for mental health difficulties (i.e., they 136 
were not recruited through a clinical setting). 137 
 138 
Measures and Procedure. All measures utilised are well-validated in clinical and 139 
non-clinical samples. Questionnaire presentation was counterbalanced in order. Specific data 140 
on socioeconomic status and educational attainment levels were not recorded. Ethical 141 
clearance, in line with APA and British Psychological Society guidelines, was granted by the 142 
local ethics committees, and participants gave informed consent prior to completing any of 143 
the measures. 144 
ANS Dysfunction. The 27-item ‘Autonomic Nervous System Reactivity’ component 145 
of the Body Perception Questionnaire (BPQ; Porges, 1993) was used as a measure of ANS 146 
dysfunction. Participants reported the frequency of experiencing physical symptoms 147 
associated with ANS dysfunction (e.g., “I get dizzy when urinating or having a bowel 148 
movement”) on a 5-point scale (1 = “Never”, 5 = “Always”). Total scores are the mean score 149 
of all items, ranging from 1 to 5, with higher scores indicating more ANS dysfunction.  150 
Depression. The 21-item Beck Depression Inventory-II (BDI-II; Beck, Steer, & 151 
Brown, 1996) was used as a measure of depression symptom severity. Participants were 152 
required to choose a statement for each item to indicate how they felt during the past two 153 
weeks. Statement scores range from 0 (e.g., “I do not feel sad”) to 3 (e.g., “I am so sad or 154 
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unhappy that I can’t stand it”). Total scores therefore range from 0 (low depression severity) 155 
to 63 (high depression severity).  156 
Anxiety. The 40-item State/Trait Anxiety Inventory (STAI; Spielberger, 1983) 157 
measured trait-anxiety symptoms through 20 items about how an individual generally feels 158 
on a 4-point scale (1 = “Almost never” to 4 = “Almost always”), and state-anxiety symptoms 159 
through 20 items about how an individual feels in that moment on a 4-point scale (1 = “Not at 160 
all” to 4 = “Very much so”). Total scores on each scale range between 20 (few symptoms) 161 
and 80 (many symptoms). 162 
Statistical Analysis. All data were analysed using SPSS 23. Data analyses were 163 
conducted in 3 stages to examine differences in ANS dysfunction between the ASD and NT 164 
groups. First, independent samples t-tests examined group differences in ANS dysfunction, 165 
depression, state-anxiety, and trait-anxiety. Second, ANCOVA tested for group differences in 166 
ANS dysfunction whilst accounting for any significant group differences in depression, state-167 
anxiety and trait-anxiety identified by the t-tests. Finally, mediation analyses modelled the 168 
relationships between group, depression, state-anxiety, trait-anxiety, and ANS dysfunction. 169 
More specifically, this tested if depression, state-anxiety, and trait-anxiety mediated group 170 
differences in ANS dysfunction. Mediation analyses were conducted using Hayes’ (2013) 171 
PROCESS macro for SPSS (Model number 4; 10,000 bootstrapped resamples). 172 
 173 
Results and Discussion 174 
In line with predictions, ANS dysfunction was significantly higher in the ASD than 175 
NT group (Table 1). Trait-anxiety, but not depression or state-anxiety, was also significantly 176 
higher in the ASD compared to NT group. Therefore, we conducted ANCOVA to compare 177 
ANS dysfunction between the groups, whilst accounting for trait-anxiety. The group 178 
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difference in ANS dysfunction was not significant, F(1,41) = 1.75, p = .19, ηp2= 0.04, 179 
whereas there was a link between trait-anxiety and ANS dysfunction, F(1,41) = 4.90, p = 180 
.032, ηp2= 0.11.  181 
Trait- and state-anxiety, and depression scores, were examined as mediators of the 182 
effect of Group (ASD, NT) on ANS dysfunction (Figure 1). Mediation analyses showed that 183 
there was an overall significant group difference in ANS dysfunction (total effect = 0.25, SE 184 
= 0.12, p = .040). However, in line with the ANCOVA, there was a mediating effect of trait-185 
anxiety on the link between ASD and ANS dysfunction (effect = 0.11, 95% bootstrapped CIs 186 
[0.00, 0.31]). There was no significant effect of state-anxiety (effect = -0.03, 95% 187 
bootstrapped CIs [-0.18, 0.05]) or depression (effect = 0.05, 95% bootstrapped CIs [-0.04, 188 
0.18]). Overall, the total indirect effect did not reach statistical significance (effect = 0.14, 189 
95% bootstrapped CIs [-0.02, 0.32]), however, after accounting for these mediating effects, 190 
the direct effect of group on ANS dysfunction was also not significant (effect = 0.11, SE = 191 
0.12, p = .36). Together, the results indicate evidence of greater ANS dysfunction in ASD 192 
compared to NT adults, broadly in line with previous research on ANS dysfunction in ASD 193 
(Benevides & Lane, 2015). Critically, however, Study 1 showed that this pattern of results 194 
was likely due to group differences in trait anxiety. 195 
The findings followed our predictions, however there were potential limitations that 196 
were addressed in a follow-up study (Study 2). First, the lack of a group difference in ANS 197 
dysfunction after accounting for anxiety may potentially reflect a false negative given the 198 
small (albeit well-characterised) sample. A widely used approach to address the lack of 199 
statistical power in autism research is to investigate the relationship between autistic traits 200 
and outcome measures in large general population samples (e.g., Shah, Livingston, Callan, & 201 
Player, 2019). We therefore used this strategy in Study 2. Second, the measure of ANS 202 
function used in Study 1, though widely-used in biological psychology (Porges, 1993), may 203 
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not be as robust as measures used by neurologists in clinical samples, such as the Composite 204 
Autonomic Symptom Score 31 (COMPASS-31; Sletten, Suarez, Low, Mandrekar, & Singer, 205 
2012). Similarly, the STAI (anxiety) and BDI-II (depression) in Study 1, which are often 206 
administered together, contain overlapping items, and therefore may not provide sufficiently 207 
independent measurement of anxiety and depression required in multivariate analyses. This is 208 
likely to explain why the link between trait-anxiety and ANS dysfunction in Study 1 was 209 
reduced after including the highly correlated depression scores. An alternative to these 210 
measures is the Depression Anxiety Stress Scale (DASS-21; Lovibond & Lovibond, 1995), 211 
which is designed to provide independent scores for depression, anxiety, and stress, and was 212 
therefore used in Study 2. Together, addressing potential limitations of Study 1, we 213 
conducted a follow-up study in a large sample of the general population to re-examine the 214 
contributions of autism, anxiety, depression, and stress to ANS dysfunction. Following Study 215 
1, we predicted that any relationship between autistic traits and ANS dysfunction would be 216 
mediated by anxiety, whilst accounting for depression and stress in the analysis.  217 
 218 
Study 2 219 
Method 220 
Participants. 480 adults (294 female) aged between 18 and 73 years (M = 27.00, SD 221 
= 10.81) formed a convenience sample recruited from online sources. Three additional 222 
participants were recruited in Study 2 but were excluded for failing to complete all the 223 
relevant measures. A power analysis (Faul, Erdfelder, Lang, & Buchner, 2007) revealed that 224 
we had at least 95% power to detect “small-to-medium” unique associations in our regression 225 
analyses (f2 = 0.04, α = .05, 2-tailed). 226 
Measures and Procedure. All measures are widely used and well-validated in 227 
clinical and non-clinical samples. They were different from measures used in Study 1 to 228 
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determine if the pattern of results could be conceptually replicated regardless of the measures 229 
used. The order of questionnaires was counterbalanced across participants, followed by 230 
questions about age and sex. Specific data on socioeconomic status and educational 231 
attainment levels were not recorded. 232 
 233 
Autistic Traits. The 28-item Short Autism-Spectrum Quotient (AQ-Short; Hoekstra et 234 
al., 2011), was used as a measure of autistic traits, with participants reporting agreement with 235 
statements on autism-like symptoms on a 4-point scale (1 = “Definitely agree” to 4 = 236 
“Definitely disagree”). Total scores range between 28 (few autistic traits) and 112 (many 237 
autistic traits).  238 
 239 
ANS Dysfunction. The 31-item Composite Autonomic Symptom Score (COMPASS-240 
31) was used as a measure of ANS dysfunction, with participants self-reporting the frequency 241 
of experiencing physical symptoms associated with ANS dysfunction. Total scores were 242 
calculated according to the standardised algorithm, such that they range between 0 (no 243 
autonomic symptoms/dysfunction) to 100 (severe autonomic symptoms/dysfunction). 244 
 245 
Depression, Anxiety, and Stress. The 21-item Depression Anxiety Stress Scale 246 
(DASS-21) was used to quantify depression, anxiety, and stress symptoms in three separate 247 
scores. Participants reported the frequency of experiencing symptoms in the last week on a 4-248 
point scale (0 = “Not at all” to 3 = “Most of the time”). Scale total scores range between 0 (no 249 
symptoms) and 42 (severe symptoms).  250 
 251 
Statistical Analysis. All data were analysed using SPSS 23. Data analyses were 252 
conducted in 3 stages to examine the relationship between autistic traits and ANS 253 
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dysfunction. First, Pearson’s correlations quantified the interrelationships between all 254 
variables. Second, multiple linear regression quantified the unique contributions of autistic 255 
traits, depression, anxiety, stress, participant age and sex to ANS dysfunction. There were no 256 
concerns of multicollinearity (Variance Inflation Factors <10), autocorrelation between 257 
residuals (Durbin-Watson = 1.78), non-normality of residuals, or extreme multivariate 258 
outliers (standardised residuals >±3 SDs from the mean). Third, using the same procedure as 259 
Study 1, mediation analyses modelled the relationships between autistic traits, depression, 260 
anxiety, stress and ANS dysfunction, whilst accounting for participant age and sex. More 261 
specifically, this tested if depression, anxiety, and stress mediated the relationship between 262 
autistic traits and ANS dysfunction.  263 
 264 
Results and Discussion 265 
In line with existing research (e.g., Hollocks et al., 2019) there were several moderate-266 
to-strong correlations, such as interrelationships between autistic trait, depression, anxiety, 267 
and stress scores (Table 2). Notably, we found that depression, anxiety, and stress, but not 268 
autistic traits, were positively correlated with ANS dysfunction. Multiple regression indicated 269 
that only anxiety, stress, and sex were significant unique predictors of ANS dysfunction, 270 
whereby greater anxiety, and stress, and being female, were uniquely associated with greater 271 
ANS dysfunction (Table 3). Importantly, neither depression scores nor autistic traits were 272 
uniquely predictive of ANS dysfunction. 273 
Mediation analysis (Figure 2) indicated that there was a significant overall effect of 274 
autistic traits on ANS dysfunction, while controlling for age and sex (total effect = 0.18, SE = 275 
0.06, p = .002). Autistic traits were weakly associated with greater ANS dysfunction, in line 276 
with the group difference identified in Study 1. However, also in line with Study 1, this 277 
relationship was mediated by anxiety (effect = 0.13, 95% bootstrapped CIs [0.07, 0.19]) and 278 
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stress (effect = 0.09, 95% bootstrapped CIs [0.03, 0.15]), but not depression (effect = 0.04, 279 
95% bootstrapped CIs [-0.03, 0.11]). More specifically, autistic traits were significantly 280 
associated with greater anxiety (b = 0.25, β = 0.33, p < .001) and stress (b = 0.28, β = 0.34, p 281 
< .001), which were subsequently linked with greater ANS dysfunction (anxiety: b = 0.52, β 282 
= 0.30, p < .001; stress: b = 0.32, β = 0.20, p < .001). The overall total indirect effect (effect = 283 
0.26) was significant (95% bootstrapped CIs [0.18, 0.35]), resulting in a non-significant 284 
direct effect of autistic traits on ANS dysfunction (effect = -0.08, SE = 0.06, p = .16). 285 
Therefore, the mediation analysis indicates the weak relationship between autistic traits and 286 
ANS dysfunction is fully and significantly mediated by anxiety and stress. Overall, across the 287 
analyses we found a weak association between autism and ANS dysfunction but, critically, in 288 
line with Study 1 and our predictions, this association was explained by the high levels of 289 
anxiety and stress that co-occur with autistic traits. Therefore, Study 2 offers a conceptual 290 
replication of Study 1, indicating a similar pattern of results irrespective of the questionnaire 291 
measures used to assess ANS dysfunction and mental health symptoms.  292 
 293 
General Discussion 294 
This was the first investigation of autism and ANS (dys)function in adulthood, whilst 295 
accounting for depression and anxiety. Using clinically relevant questionnaire measures, we 296 
found that autistic individuals reported greater ANS dysfunction than NT individuals, 297 
specifically, reporting more ANS related physical health symptoms. However, this group 298 
difference was smaller – and no longer significant – after controlling for anxiety (Study 1). 299 
Similarly, in a general population sample, autistic traits were associated with greater ANS 300 
dysfunction, but this relationship was mediated by anxiety and stress (Study 2). In summary, 301 
our results indicate that ANS dysfunction in ASD, and the associated physical symptoms, is 302 
likely due to co-occurring anxiety and stress, rather than autism per se.  303 
Running head: AUTONOMIC DYSFUNCTION IN AUTISM 
14 
 
Until now, it was unclear whether ANS dysfunction was a feature of ASD, given 304 
previously inconsistent results from studies on this topic. Our results shed new light on this. 305 
Across two studies using two different self-report measures of ANS dysfunction, we found 306 
evidence for a weak link between autism and ANS dysfunction, in line with some previous 307 
research using physiological measures of ANS function (e.g., Thapa et al., 2019). Equally, 308 
because this association was not significant after controlling for anxiety and depression, this 309 
was effectively in line with other reports of no link between autism and ANS function (e.g., 310 
Smeekens et al., 2015). Importantly, therefore, our findings indicate that previous studies 311 
may have generated conflicting results by not accounting for the co-occurrence between 312 
autism and other mental health difficulties, most notably anxiety. Accordingly, the critical 313 
finding of the present study is that an already weak association between ASD and ANS 314 
dysfunction is best explained by co-occurring anxiety. This is consistent with emerging 315 
research, albeit limited to date, which has included measures of anxiety when exploring ANS 316 
function in children with ASD (see McVey, 2019). The present findings support and extend 317 
this literature to adult samples. Moving forward, we suggest that theoretical and 318 
methodological consideration of anxiety is crucial for advancing understanding of the 319 
nervous system in ASD, hence anxiety measures should be included in any research 320 
investigating ANS function in autism. For example, anxiety can practicably be measured 321 
using quick-to-administer tools – in adults with and without ASD – which are routinely used 322 
in clinical practice (e.g., 7-item Generalised Anxiety Disorder Assessment; GAD 7; Spitzer, 323 
2006). These data could then be used for research purposes. More broadly, the extent to 324 
which anxiety partly, or even fully, explains other symptoms in ASD (e.g., sensory over-325 
responsivity; Green & Ben-Sasson, 2010) also requires further investigation. 326 
Our findings suggest that, alongside anxiety, stress plays a role in the relationship 327 
between autism and ANS dysfunction. The principal reason for quantifying stress was to 328 
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ensure that anxiety and depression could be measured with greater precision to test their 329 
unique influences, if any, on ANS function. This however gave rise to the novel finding that 330 
stress uniquely mediated the link between autistic traits and ANS dysfunction. While the 331 
causes of stress and anxiety differ, and they are separate constructs, they are likely to have a332 
similar influence on the ANS. Indeed, recent evidence suggests that they influence ANS 333 
function via the shared symptom of pathological worry (Chalmers, Heathers, Abbott, Kemp, 334 
& Quintana, 2016). This indicates that, in future research on ANS function in autism 335 
spectrum and anxiety disorders, it is worth measuring stress to i) include within statistical 336 
analysis, but more fundamentally, ii) explore the psychopathological mechanisms underlying 337 
the overlap between stress, anxiety, and the ANS. More broadly, there has been widespread 338 
research on anxiety in ASD, but almost none on stress in autistic children and adults. The 339 
present study indicates that, although ANS dysfunction is unlikely to be a core feature of 340 
autism, theoretical consideration and measurement of stress alongside anxiety may benefit 341 
future research on the ANS and other neurobiological systems in ASD. 342 
Additionally, across both studies, we found that depression was not associated with 343 
ANS dysfunction in ASD once anxiety and stress were accounted for. This adds much clearer 344 
evidence to an otherwise mixed literature on the link between depression and ANS 345 
dysfunction (Alvares et al., 2016). Indeed, our results suggest, in line with other studies (e.g., 346 
Bajkó et al., 2012), that depression has minimal or no link with ANS function, especially 347 
when compared to the greater influence of anxiety. The current findings therefore extend this 348 
lack of relationship between depression and ANS function to the ASD population. Given the 349 
divergent contributions of anxiety and depression to ANS function, questionnaires that make 350 
clear distinctions between anxiety and depression symptoms, such as the DASS, will benefit 351 
future research on ANS dysfunction in ASD and clinical psychological science more 352 
generally.  353 
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Our findings also have other broader implications for research and clinical practice. 354 
First, the findings have important implications for clinical management of ‘physical’ illnesses 355 
and symptoms that may be caused or exacerbated by co-occurring conditions in ASD. 356 
Specifically, our findings indicate that anxiety may contribute to the ANS-related ‘physical’ 357 
health concerns widely observed in ASD (e.g., sleep, sensory, and gastrointestinal issues; 358 
Mazurek et al., 2013). This in turn suggests that targeting anxiety, rather than autism 359 
symptoms, may be a more effective treatment for physical health symptoms in ASD. This is 360 
in line with research showing, for example, that Cognitive Behavioral Therapy (CBT) can 361 
help alleviate sleep difficulties in autistic children (e.g., Tilford et al., 2016). CBT may also 362 
hold promise for treating other ANS-related symptoms in ASD, such as gastrointestinal 363 
issues, through reducing anxiety and stress. Interestingly, a randomised control trial (RCT) in 364 
non-autistic individuals recently found that CBT was a more effective treatment for 365 
gastrointestinal issues than changes to diet and lifestyle (Everitt et al., 2019). RCTs of CBT in 366 
ASD have not yet considered their consequences for ameliorating ANS-related physical 367 
health difficulties. If successful, CBT may offer an easily accessible and non-invasive 368 
approach for the better management of both anxiety and other physical health issues in ASD. 369 
This may in fact be preferable to pharmacological treatments for anxiety, which may 370 
exacerbate ANS dysfunction (see Alvares et al., 2016). With that said, the potential 371 
(bi)directionality of the relationship between anxiety and ANS dysfunction is poorly 372 
understood. It is equally possible that treatments for ANS dysfunction, including 373 
pharmacological treatment and lifestyle/diet changes, would alleviate anxiety in ASD. This 374 
requires further investigation. 375 
Second, our findings highlight the utility of self-report questionnaire measures of 376 
ANS symptoms alongside, or instead of, physiological measures (e.g., HR). As questionnaire 377 
measures are less time consuming, resource-dependent, and assess ANS function across a 378 
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range of domains, they may have utility in research and clinical settings where specialist 379 
physiological equipment is unavailable. We therefore suggest that future development and 380 
validation of abbreviated questionnaires measuring ANS symptoms will be particularly 381 
fruitful for use in applied research and clinical practice.  382 
Finally, in terms of research, the present study highlights the general importance of 383 
accounting for co-occurring conditions when investigating overlapping psychological 384 
constructs and cognitive mechanisms, particularly those associated with ASD. Indeed, more 385 
often than not, ASD and NT samples differ in many other clinically relevant phenomena (see 386 
also, Shah et al., 2019). There are a range of so called ‘core’ autistic features that may be 387 
attributable to other conditions that co-occur with autism and these require greater 388 
consideration in research (e.g., alexithymia; Shah, Hall, Catmur, & Bird, 2016). 389 
The current study’s strengths include the use of clinically relevant questionnaires, 390 
which led to a convergent pattern of results across a case-control and general population 391 
study. Through replicating the results using different measures of ANS dysfunction and 392 
mental health symptoms, we were able to mitigate against potential concerns about construct 393 
validity in our studies. However, further research is required to address notable limitations. 394 
First, although the large sample size in Study 2 enabled statistically powerful analyses, there 395 
are ongoing debates regarding the appropriateness of using population-level autistic traits as a 396 
proxy for understanding ASD (e.g., Coghill & Sonuga-Barke, 2012). Therefore, replication of 397 
our findings in larger, heterogeneous, samples of individuals with clinically diagnosed ASD 398 
is required. Similarly, we used clinically relevant questionnaires to assess depression and 399 
anxiety rather than comparing individuals with(out) a clinical diagnosis of these disorders. 400 
This approach was taken as it allowed us to model the severity/frequency of the anxiety and 401 
depression symptoms relative to the severity/frequency of ANS dysfunction. Nonetheless, the 402 
present study could be replicated and extended by comparing autistic adults with and without 403 
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clinical diagnoses of anxiety and depression. Second, our data cannot speak to the 404 
directionality or neurobiological mechanisms underpinning the links between anxiety, stress, 405 
and ANS dysfunction. Moving forward, such research will be crucial for informing 406 
(pharmacological) interventions to alleviate ANS-related physical and mental health 407 
difficulties in ASD. Relatedly, although we excluded participants taking medication that 408 
primarily target cardiac function, we did not exclude those taking medication that may 409 
indirectly have influenced cardiac and ANS function. It is therefore possible that our pattern 410 
of results was partly explained by the potentially greater use of such medications in adults 411 
with ASD and anxiety. Future research would benefit from disentangling the contribution of 412 
pharmacological substances vs core physiological features of various conditions on ANS 413 
function and related physical health disorders (see also, Alvares et al., 2016). Finally, it is 414 
unclear if our pattern of results will hold using physiological measures of ANS function, 415 
where mixed results continue to emerge (see McVey, 2019). It is difficult to synthesise our 416 
findings with previous research that has been reliant on physiological measures, particularly 417 
as most of it has been conducted in samples of children with autism. Therefore, future studies 418 
using both questionnaire and physiological measures of the ANS, particularly in dult 419 
samples, will be of great interest and the present study provides the impetus for this research. 420 
  421 
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Table 1  532 
Participant Characteristics and Group Comparisons - Study 1. 533 
Measure Group Group Comparisons 
 ASD NT t 95% CIs p d 
Sex (male, 
female)a 
16, 6  13, 9 0.91  .34  










































1.47 -1.72, 10.90 .15 0.44 
Note. Values are means with standard deviations in parentheses. Group differences between 534 
means (t) and respective significance levels (p) and effect sizes (d) are reported. aA Chi-535 
Square is reported for the group difference in male: female ratio. 95% Confidence Intervals 536 
are presented for the mean difference. ANS: Autonomic Nervous System; ASD: Autism 537 
Spectrum Disorder; CIs: Confidence Intervals; IQ: Intelligence Quotient; NT: Neurotypical. 538 
 539 
  540 
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Table 2 541 
Means and Correlations – Study 2. 542 
Measure M (SD) 1 2 3 4 5 6 
1. Autistic Traits 62.21 (10.25) -      
2. Depression 10.83 (9.57) .45*** -     
3. Anxiety 8.52 (7.57) .29*** .57*** -    
4. Stress  12.73 (8.42) .31*** .66*** .70*** -   
5. ANS Dysfunction  19.68 (13.12) .08 .33*** .49*** .45*** -  
6. Age in years  27.00 (10.81) .16** -.03 -.21*** -.11* -.22*** - 
Note. *p < .05** p < .01, *** p < .001. ANS: Autonomic Nervous System. 543 
 544 
Table 3 545 
Multiple Regression Analysis Predicting Autonomic Nervous System (ANS) Dysfunction – 546 
Study 2. 547 
Predictor Variables B SE B β sr2 p 
Autistic Traits  -0.08 
(-0.19, 0.03) 
0.06 -0.06 0.003 .16 
Depression  0.09 
(-0.06, 0.24) 
0.08 0.07 0.002 .25 
Anxiety  0.52 
(0.33, 0.71) 
0.10 0.30 0.042 <.001 
Stress  0.32 
(0.14, 0.50) 
0.09 0.21 0.017 .001 
Age in years -0.10 
(-0.20, 0.00) 
0.05 -0.08 0.005 .055 
Sex (0 = Female, 1 = Male) -3.94 
(-6.12, -1.76) 
1.11 -0.15 0.018 <.001 
Overall Model Fit F(6, 473) = 33.74, p<.001, R2  = .291 
Note. 95% Confidence Intervals are shown in parentheses. 548 
 549 







Figure 1. The Mediating Effect of Trait-anxiety, Depression and State-anxiety on the 554 
Relationship between Group (ASD = 1, NT = 0) and ANS Dysfunction in Study 1. Note: *p< 555 
.05; all coefficients are unstandardised; ANS: Autonomic Nervous System; ASD: Autism 556 
Spectrum Disorder; NT: Neurotypical. 557 
  558 








Figure 2. The Mediating Effect of Anxiety, Depression, and Stress on the Relationship 564 
between Autistic Traits and ANS Dysfunction in Study 2. Note: * p < .05, ** p < .01, *** p < 565 
.001; all coefficients are unstandardised, and account for age and sex; ANS: Autonomic 566 
Nervous System.  567 
